Podcast: The Week In European Consumer Health Industry News, 12 April 2021
HBW editors Tom Gallen and David Ridley discuss the big issues in the European consumer health market from the past week. In this edition, they take a look at the potential for cannabidiol supplements to be regulated as drugs in the future, and also explore the options for UK CBD players now the FSA’s novel food validation deadline has passed.
You may also be interested in...
Stada’s Natures Aid Expands UK Children’s Wellness Lines
Stada Arzneimittel’s UK dietary supplement subsidiary Natures Aid is expanding its Mini Drops and Super Stars children’s wellness brands with new products.
People On The Move: Appointments At AESGP, Alliance Pharma, FSE, Venture Life
A round-up of the latest appointments in Europe's consumer health industry: AESGP names Haleon's Workman as president; Alliance Pharma shareholders re-elect board; Food Supplements Europe re-elects Stada's Šímová as chair; and Venture Life announces departure of co-Founder and CCO Daly.
Sweden Drops Plans For Max Levels In Supplements After Commission Consultation
Sweden will not introduce proposed limits for vitamin D and iodine in dietary supplements after the European Commission warned it would create a disproportionate barrier to trade with other EU member states.